GLADYS GRACE ANDRES LLAGUNO: Open Payments
NPI 1043677602 · OCEANSIDE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,924 in 75 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $959 · 2025 $1,924
Food & beverage: $1,924
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $795 |
| Collegium Pharmaceutical, Inc. | 8 | $255 |
| Neurocrine BioSciences, Inc. | 5 | $149 |
| Supernus Pharmaceuticals, Inc. | 3 | $146 |
| Corium, LLC | 7 | $116 |
| Evofem Biosciences, Inc. | 6 | $94 |
| Neurelis, Inc. | 3 | $79 |
| Alexion Pharmaceuticals, Inc. | 3 | $75 |
| UCB, Inc. | 3 | $53 |
| Eisai Inc. | 2 | $37 |
Products named: BOTOX, Jornay PM, QULIPTA, UBRELVY, INGREZZA, Qelbree, Azstarys, Phexxi.
Industry payments across NY — which companies pay providers there.
